Hi SC & Aaron, respect both opinions.
It's a bit simplistic but lets say the price (which BTW is the analysts opinion, not from the company) is only $500 a dose. The NPV would then be approximately $0.52. It seems the analysts believes that the target should be 50% of that so we arrive at 26c.
We're not far off what it is worth if it was priced at $500 a dose. No off-label use, no other indications etc etc.
I'm ok with this, for the moment anyway.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$11.93 |
Change
-0.320(2.61%) |
Mkt cap ! $597.9M | |||
| Open | High | Low | Value | Volume |
| $12.25 | $12.28 | $11.44 | $1.963M | 165.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 891 | $11.90 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $11.93 | 444 | 1 |
View Market Depth
| Last trade - 16.10pm 23/07/2025 (20 minute delay) ? |
| CUV (ASX) Chart |